Vitakey, Inc.
Publicly observedWashington, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Washington | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Vitakey, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | SUPCXTUWSCZ9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jun 2025Publicly observed
NIH SBIR/STTR award: Platform technology for delivery of stabilized therapeutic microbes in powders with high water activity
USD 349,759.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)
- Grant1 Feb 2023Publicly observed
NIH SBIR/STTR award: Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestines
USD 607,851.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Feb 2023Publicly observed
NIH SBIR/STTR award: Stabilization of therapeutic microbes for inclusion in a liquid matrix for delivery to the intestines
USD 1,437,278.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.